0
0
0
s2sdefault

Members of the European Parliament are much more likely to recognise the reduced risk of e-cigarettes and other novel nicotine products if they have some knowledge of the subject, new research reveals. A survey conducted by ECigIntelligence and TobaccoIntelligence found that 70% of MEPs with some knowledge of e-cigarettes considered them less harmful than smoking, against just 41% of MEPs with no knowledge of the topic.

“When it comes to politicians’ perceptions of new nicotine products, accurate information appears to make all the difference,” said Tim Phillips, managing director of ECigIntelligence and TobaccoIntelligence [...]

0
0
0
s2sdefault

The use of e-cigarettes by Irish teenagers has almost doubled . Research has found vaping has risen rapidly among adolescents with the current number of teenagers using e-cigarettes jumping from 10pc to 18pc between 2015 and 2019.

While e-cigarettes have been used as a technology to help people quit their tobacco habit, there is concern globally about the numbers of non-smoking adolescents taking up vaping.

Experts say the long-term effects are unknown, but there is concern that e-cigarettes are a worrying route into nicotine addiction.

0
0
0
s2sdefault

You may have noticed that vaping has attracted some attention over the last couple of years, though the practice has been around, or at least in the making, for almost 100 years. Before giving you reasons as to why you should throw away your cigarettes and switch to vapes, here is some history. The first idea to replace a combustible cigarette dates back nearly a century, when Joseph Robinson filed a patent back in 1927, for a device that would make use of electricity to heat tobacco instead of burning it. The device never made it to the market and following another couple of patent filings, [...]

0
0
0
s2sdefault

Upstart e-cigarette makers are vying to get their products prescribed on the NHS, as they target a potentially lucrative new market before Big Tobacco commits to the lengthy licensing process. [...]
Several companies are now pursuing a medicines authorisation. NJOY, which has 3.9 per cent of the $5bn US market, according to Nielsen data, is “far on in the development of its application”, a person close to the company said.

 

NJOY considers medical licensing an opportunity to expand into the UK, where it has a limited presence, they added.